Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease

Published:2018-09-19 Issue:11 Volume:12 Page:1316-1325
ISSN:1873-9946
Container-title:Journal of Crohn's and Colitis
language:en
Short-container-title:

Author:

van Hoeve Karen¹²,Dreesen Erwin³,Hoffman Ilse¹,Van Assche Gert²⁴,Ferrante Marc²⁴,Gils Ann³,Vermeire Séverine²⁴

Affiliation:

1. Department of Paediatric Gastroenterology & Hepatology & Nutrition, University Hospitals Leuven, KU Leuven, Leuven, Belgium

2. TARGID, Department of Chronic Diseases, Metabolism and Ageing [CHROMETA], KU Leuven, Leuven, Belgium

3. Laboratory for Therapeutic and Diagnostic Antibodies, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

4. Department of Gastroenterology & Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium

Funder

Mundipharma Comm. VA and Celltrion Healthcare Co.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Link

http://academic.oup.com/ecco-jcc/article-pdf/12/11/1316/26571639/jjy111.pdf

Reference63 articles.

1. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children;Hyams;Gastroenterology,2007

2. Safety and efficacy of adalimumab for moderate to severe Crohn’s disease in children;Hyams;Gastroenterology,2012

3. Induction andtenance therapy with infliximab for children with moderate to severe ulcera maintive colitis;Hyams;Clin Gastroenterol Hepatol,2012

4. Mucosal healing in pediatric Crohn’s disease after anti-TNF therapy: a long-term experience at a single center;Nobile;Eur J Gastroenterol Hepatol,2014

5. Anti-TNF therapy for paediatric IBD: the Scottish national experience;Cameron;Arch Dis Child,2015

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. To evaluate the predictive effect of vitamin D on clinical outcomes of infliximab treated Crohn’s disease patients in western China;2024-07-27

2. The role of proactive therapeutic drug monitoring in guiding infliximab therapeutic optimization in pediatric patients with Crohn's disease: A retrospective study;Pediatric Discovery;2024-06-25

3. Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2024-05-02

4. Infliximab Monotherapy vs Combination Therapy for Pediatric Crohn’s Disease Exhibit Similar Pharmacokinetics;Inflammatory Bowel Diseases;2024-01-03

5. Early infliximab trough levels in paediatric IBD patients predict sustained remission;Therapeutic Advances in Gastroenterology;2023-12-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3